Skip to content
Disclosery

EXANE DERIVATIVES: CRBN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CRBN, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 8,138 CRBN shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 8,138 shares
    Change vs previous 13F -1,675 shares

    0.64% of the 13F portfolio, value $1,113,133.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 9,813 shares
    Change vs previous 13F -327 shares

    0.45% of the 13F portfolio, value $1,602,070.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 10,140 shares
    Change vs previous 13F +968 shares

    0.43% of the 13F portfolio, value $1,763,992.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 9,172 shares
    Change vs previous 13F +4,649 shares

    0.38% of the 13F portfolio, value $1,506,814.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,523 shares
    Change vs previous 13F +3,688 shares

    0.18% of the 13F portfolio, value $758,625.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 835 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $130,371.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).